Medical device having a surface comprising nanoparticles

US9889237B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9889237-B2
Application numberUS-201313875355-A
CountryUS
Kind codeB2
Filing dateMay 2, 2013
Priority dateMay 11, 2012
Publication dateFeb 13, 2018
Grant dateFeb 13, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A medical device has a surface intended for contact with living tissue, wherein the surface comprises nanoparticles comprising a non-toxic post-transition metal such as gallium and/or bismuth, said nanoparticles having an average particle size of 500 nm or less. The nanoparticles may provide an antimicrobial effect, and thus the risk for infection may be reduced.

First claim

Opening claim text (preview).

The invention claimed is: 1. A medical device, which is a dental implant intended for implantation at least partially into living tissue, said dental implant comprising a non-bioresorbable substrate having a surface intended for contact with living tissue, wherein the surface includes a homogenous monolayer of nanoparticles comprising titanium dioxide, bismuth nitride, and gallium nitride, the monolayer of nanoparticles having a thickness from 100 nm to 400 nm with said nanoparticles having an average particle size of 500 nm or less. 2. The medical device according to claim 1 , wherein said nanoparticles of titanium dioxide have an average particle size of 100 nm or less. 3. The medical device according to claim 1 , wherein said medical device comprises a substrate having said surface, which substrate comprises a metal or an alloy. 4. The medical device according to claim 3 , wherein said substrate comprises titanium, zirconium, hafnium, vanadium, niobium, tantalum, cobalt or iridium, or an alloy thereof. 5. The medical device according to claim 1 , wherein the dental implant is a dental fixture intended to be inserted at least partially into living bone tissue. 6. The medical device according to claim 1 , wherein the dental implant is a dental abutment, intended to be in contact with living soft tissue. 7. A method of implanting a medical device into the living body of a human or animal, the method comprising: a) providing a medical device according to claim 1 ; and b) implanting said medical device into said living body of a human or animal, wherein the medical device is positioned such that at least part of the surface comprising nanoparticles comprising a non-toxic post-transition metal is in contact with living tissue.

Assignees

Inventors

Classifications

  • Other specific inorganic materials not covered by A61L27/303 - A61L27/32 · CPC title

  • Inorganic materials · CPC title

  • Inorganic materials · CPC title

  • A61C8/00Primary

    Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools (fastening of peg-teeth in the mouth A61C13/30) · CPC title

  • for dental implants or prostheses · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9889237B2 cover?
A medical device has a surface intended for contact with living tissue, wherein the surface comprises nanoparticles comprising a non-toxic post-transition metal such as gallium and/or bismuth, said nanoparticles having an average particle size of 500 nm or less. The nanoparticles may provide an antimicrobial effect, and thus the risk for infection may be reduced.
Who is the assignee on this patent?
Dentsply Int Inc, Dentsply Sirona Inc
What technology area does this patent fall under?
Primary CPC classification A61C8/00. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).